You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Immunogenicity of Inactivated Hepatitis A Vaccine in Children With Chronic Liver Disease

Majda-Stanislawska, Ewa MD; Bednarek, Malgorzata MD; Kuydowicz, Jan MD

Pediatric Infectious Disease Journal:
Brief Reports
Abstract

One and 6 months after vaccination with hepatitis A virus vaccine (HAVRIX 720 Junior), immunologic responses (anti-hepatitis A virus ≥20 mIU/ml) in children with chronic hepatitis C infection seroprotection were 92% (23/25) and 75% (9/12) in children with chronic hepatitis B infection 87% (21/24) and 88% (15/17) and in healthy children 91% (20/22) at both times. A booster dose induced seroprotection in all children.

Author Information

From the Department and Clinic of Infectious Diseases and Hepatology, Medical University of Lodz, Lodz, Poland

The vaccines and anti-HAV antibody tests used for the study were sponsored by GlaxoSmithKline Biologicals. None of the authors has any other potential conflict of interests related to the work.

Accepted for publication January 30, 2004.

Reprints not available.

© 2004 Lippincott Williams & Wilkins, Inc.